|
Sep 23
|
T2 Biosystems Highlights New Article Published in The Lancet: Changing the Culture of Blood Culture
|
|
Aug 27
|
T2 Biosystems to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
|
|
Jul 30
|
Q2 2024 T2 Biosystems Inc Earnings Call
|
|
Jul 29
|
T2 Biosystems: Q2 Earnings Snapshot
|
|
Jul 29
|
T2 Biosystems Announces Second Quarter 2024 Financial Results
|
|
Jul 29
|
T2 Biosystems Announces Commercial Expansion Through Malaysia and Indonesia Distributor
|
|
Jun 25
|
T2 Biosystems Announces Commercial Expansion Through Hong Kong and Macau Distributor
|
|
May 15
|
Sector Update: Health Care Stocks Advance Late Wednesday Afternoon
|
|
May 15
|
T2 Biosystems Announces $8 Million Private Placement Priced At-The-Market Under Nasdaq Rules
|
|
May 14
|
T2 Biosystems Announces CRG’s Conversion from Preferred Stock to Common Stock
|
|
May 7
|
T2 Biosystems Announces Letter of Intent to Enter Strategic Partnership for Lyme Disease
|
|
May 7
|
T2 Biosystems, Inc. (NASDAQ:TTOO) Q1 2024 Earnings Call Transcript
|
|
May 7
|
Q1 2024 T2 Biosystems Inc Earnings Call
|
|
May 7
|
T2 Biosystems Inc (TTOO) Q1 2024 Earnings Call Transcript Highlights: Revenue Growth Amidst ...
|
|
May 6
|
T2 Biosystems Announces Commercial Expansion Through Middle East Distributor
|
|
May 6
|
T2 Biosystems Announces First Quarter 2024 Financial Results
|
|
May 6
|
T2 Biosystems Announces the Conversion of an Additional $15 Million of CRG Term Loan into Equity
|
|
Apr 24
|
T2 Biosystems to Report First Quarter 2024 Financial Results and Business Updates on May 6, 2024
|
|
Apr 11
|
T2 Biosystems Shareholders Vote for CRG Debt Conversion into Equity
|
|
Mar 28
|
T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.
|